Exchange: OTC·Updated 03:21 PM EST

NYMXF Nymox Pharmaceutical Corp

$0.02
$0.0091
(83.49%)
Today
Mkt Cap$2.1M
Vol1,100.00

About NYMXF

Nymox Pharmaceutical Corp. engages in the research and development of products for the aging population. Its products include NicAlert, TobacAlert and Fexapotide Triflutate for the treatment of low-grade localized prostate cancer. The company was founded by Paul Averback on May 30, 1995 and is headquartered in Nassau, the Bahamas.
46

Neutral Sentiment

How do you feel about NYMXF?

usa2018
$NYMXF I thought we had a new Board of Directors that was going to step it up and put Nymox in the right direction! Well, As the rock band The Who sings…. Yeah Meet the New Board Same as the Old Board There is nothing in the street Looks any different to me I’ll get on my knees and pray We don’t get fooled again by that Dr A Yeah Meet the New Board Same as the Old Board
4
usa2018
$NYMXF looks like some lucky kid just got 3 shares of Nymox in their college fund. Won’t they be surprised.
2
IP_Slow
$NYMXF does anybody have an update on the Olshan vs CRNSV lawsuit? I am afraid this one is going to leave a mark
1

Advertisement|Remove ads.